De novo three-way chromosome translocation 46,XY,t(4;6;21)(p16;p21.1;q21) in a male with cleidocranial dysplasia by Purandare, Smita M et al.
 2008 Wiley-Liss, Inc. American Journal of Medical Genetics Part A 146A:453–458 (2008)
Clinical Report
De Novo Three-Way Chromosome Translocation
46,XY,t(4;6;21)(p16;p21.1;q21) in a Male
With Cleidocranial Dysplasia
Smita M. Purandare,
1 Roberto Mendoza-Londono,
2,3 Svetlana A. Yatsenko,
2 Dobrawa Napierala,
2
Daryl A. Scott,
2 Tarek Sibai,
2 Kari Casas,
1 Patrick Wilson,
1 Jiyun Lee,
1 Razia Muneer,
1
Joe C. Leonard,
4 Faridali G. Ramji,
4 Ralph Lachman,
5 Shibo Li,
1 Pawel Stankiewicz,
2
Brendan Lee,
2,6 and John J. Mulvihill
1*
1Section of Genetics, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
2Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
3Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, Toronto, Canada
4Department of Radiological Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
5International Skeletal Dysplasia Registry, Cedars Sinai Medical Center, Los Angeles California
6Howard Hughes Medical Institute, Chevy Chase, Maryland
Received 6 June 2006; Accepted 10 February 2007
Cleidocranial dysplasia (CCD) is an autosomal dominant
skeletal dysplasia associated with cranial, clavicular, and
dental anomalies. It is caused by mutations in the RUNX2
gene, which encodes an osteoblast-speciﬁc transcription
factor and maps to chromosome 6p21. We report clinical and
molecular cytogenetic studies in a patient with clinical
features of CCD including wormian bones, delayed fontanel
closure, hypoplastic clavicles and pubic rami, and super-
numerary dentition. Additional abnormalities of bone
growth and connective tissue, including easy bruisability,
scarring, bleeding, joint hypermobility, and developmental
delay were also observed. Molecular cytogenetic studies
identiﬁed a de novo apparently balanced three-way translo-
cation 46,XY,t(4;6;21)(p16;p21.1;q21). Further mapping
revealed the breakpoint on 6p21 to be  50 kb upstream of
exon 1 of the RUNX2 gene, with RUNX2 being intact on the
derivative chromosome 6. We hypothesize that the pro-
band’s CCD has arisen from disruption of the developmen-
tally regulated gene RUNX2 at the 6p21 breakpoint, due to
a position effect mutation which may have altered the
expression of the gene. Further studies might unravel a new
regulatory element for RUNX2.  2008 Wiley-Liss, Inc.
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INTRODUCTION
Cleidocranial dysplasia (CCD: OMIM 119600) is
an autosomal dominant skeletal dysplasia affecting
bones derived from endochondral and intramem-
branous ossiﬁcation. The diagnosis of CCD is based
on clinical and radiological ﬁndings [Mendoza-
Londono and Lee, 2006]. Hallmark features of CCD
include large open fontanels with delayed or absent
closure, midface hypoplasia, abnormal dentition
including supernumerary teeth, clavicular hypopla-
sia, and hand abnormalities such as brachydactyly
[TaybiandLachman,1996].Intellectualdevelopment
is usuallynormal in patientswith CCD[Cooper etal.,
2001]
SkeletalelementsofpatientswithCCDshowdisorder-
edregulationofendochondralandintramembranous
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DOI 10.1002/ajmg.a.31750ossiﬁcation [Zheng et al., 2005]. Sixty to seventy
percent of cases of CCD are caused by mutations
in the gene encoding transcription factor RUNX2
(runt-related transcription factor 2) located on
chromosome 6p21 [Lee et al., 1997; Mundlos et al.,
1997]. The mutations include missense, deletion,
splice, insertion, and nonsense mutations [Zhou
et al., 1999, Yoshida et al., 2002]. Microdeletions of
the gene have also been reported [Gelb et al., 1995,
Mundlos et al., 1995, Izumi et al., 2006]. RUNX2
is a transcription factor essential for osteoblast
differentiation and chondrocyte maturation during
endochondral ossiﬁcation [Zheng et al., 2005].
Heterozygote RUNX2 mice display abnormalities
similar to individuals with CCD [Shapiro, 1999]. The
expression of RUNX2 during development is regu-
lated by at least two separate promoters. Additional
enhancerelementsupstreamofthegenealsomodify
its expression [Stock and Otto, 2005].
We present a patient with skeletal ﬁndings
consistent with CCD and additional atypical ﬁndings
including learning disability, developmental delay,
and features suggestive of connective tissue dis-
orders including easy bruising, joint laxity, and
dislocations. We identiﬁed a complex translocation
involvingthreechromosomesandcarriedoutfurther
molecularinvestigationstodeterminetheintegrityof
the RUNX2 gene on 6p21 (region involved in the
translocation), which has been implicated in the
causation of CCD.
CLINICAL REPORT
A presently 17-year-old Caucasian male was
recognized at 3 years of age to have a complex
chromosome translocation involving chromosomes
4p, 6p, and 21q, while being evaluated for develop-
mental delay and minor dysmorphisms including a
large head, short stature, hypertelorism, and super-
numerarydentition.Nospeciﬁcsyndromicdiagnosis
was made. Nearly a decade later, he presented with
severe joint pain, bleeding tendencies, and delayed
puberty, and a clinical and cytogenetic re-evaluation
was done.
Intheintervalhehadpolydontiarequiringremoval
of supernumerary teeth, umbilical hernia repair,
normal CT of the head at age 11 years, obstructive
sleep apnea syndrome requiring tonsillectomy and
adenoidectomy, and septoplasty (open reduction
of nasal fracture with repair of septum). Due to
recurrent epistaxis and left nasal polyps he had
removal of the polyps, which showed histopatholo-
gical features of developing angioﬁbromas. In
addition to the large cranium, abnormal dentition,
short stature, scoliosis, joint laxity, and recurrent
respiratory infections, all features of CCD, he also
had learning disability which is not a feature typical
of CCD.
Abnormalities of bone growth and connective
tissue evolved over time. At 14 years of age (Fig. 1),
he complained of easy bruisability, scarring, bleed-
ing, joint pain, increased shoulder motion, and
occasional shortness of breath during heavy exer-
cise. Pubertal development was delayed. Height,
weight, and head circumference were at the 25th,
50th,and80thcentiles,respectively.Hehadsoftskin
with multiple bruises. His face was asymmetric with
leftward deviation of the nose. There was kyphosis
with a slight rightward deviation. He had pes planus
along with hypoplastic fourth and ﬁfth toenails,
bilaterally. He could actively dislocate his thumb,
knees, and hip. He had bilateral contractures at
the elbows, and two cafe-au-lait macules. Endocrine
studies showed normal gonadotropin levels. At
age 16 years, height was at the 20th centile, weight
was at the 80th centile, and occipital–frontal
circumference was at the 98th centile. Pubertal
development was Tanner III for male pubic hair.
Bilaterally there was decreased supination and
extensionoftheelbowsandshoulders. Theclavicles
are diminutive allowing excessive adduction of the
shoulders.
Skeletal survey at age 14 years (Fig. 2) showed
features consistent with CCD, including wormian
bones,shortclavicles,posteriorwedgingofvertebral
bodies in the thoracic and lumbar spine, hypoplastic
pubic bones and ischia, coxa valga, and long
metacarpals and phalanges with supernumerary
FIG.1 .Clinical ﬁndings at age 14 years. [Color ﬁgure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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carpals one, two, and ﬁve.
RESULTS
Cytogenetic analysis and ﬂuorescence in situ
hybridization (FISH) with selected probes identiﬁed
an abnormal male karyotype with an apparently
balancedtranslocation46,XY,t(4;6;21)(p16;p21.1;q21)
(Fig. 3). Both parents had normal karyotypes. FISH
analysis was performed on metaphase cells with a
combination of whole chromosome painting probe
6 and a Wolf–Hirschhorn syndrome (WHS) locus-
speciﬁc probe on chromosome 4p16.3. Locus-
speciﬁc probes for chromosome 21 (LSI21, 21q22)
were also used. A locus-speciﬁc probe, AML1,a
subtelomericprobeof21q,andwholechromosomal
paint probes of chromosomes 4 and 21 were also
used on the father’s peripheral blood sample. All
the probes were purchased from a commercial
source (Vysis, Downers Grove, IL) and used accord-
ing to the manufacturer’s protocols with minor
modiﬁcations. BAC, PAC, and fosmid clones spann-
ing the 6p21 region were selected from the UCSC
genome database (http://genome.ucsc.edu) and
obtained from the BACPAC Resource Center (http://
www.chori.org/bacpac).
Given the facts that the patient had a CCD
phenotype and that the translocation involved the
genomic location of RUNX2, we performed FISH
analysis with three probes spanning the RUNX2
locus. We used clones RP1-244F24 (AL096865),
RP11-342L7 (AL358135), and RP1-166H4 (AL161907),
which cover the promoter and entire coding region
of the gene (Fig. 4a). Probes RP11-342L7 and RP1-
166H4 showed signals only on the normal and
derivative chromosome 6, and probe RP1-244F24
showed signals on the normal and derivative
chromosome 6 as well as on chromosome 21. In
order to reﬁne the breakpoint on the derivative
chromosome 6, we performed FISH using over-
lapping fosmids G248P80212A10, G248P86676H4,
G248P8418A1, and G248P86565D3 located up-
stream of the RUNX2 gene (Fig. 4a). Fosmid clones
G248P86676H4, G248P8418A1, and G248P86565D3
located immediately upstream of the RUNX2 gene
produced hybridization signal on the normal and
derivative chromosome 6 only, suggesting that the
entire coding sequence of RUNX2 including its
promoterremainedintactontheder(6)chromosome
and was not translocated (Fig. 4b). Signals from
fosmid G248P80212A10 were seen on the normal
chromosome 6 and both derivative chromosomes
6 and 21 (breakpoint clone). This result maps the
breakpoint on chromosome 6p21 to a region
approximately 50 kb upstream of the RUNX2 gene
based on the genetic mapping position of
G248P80212A10 and RUNX2 on the UCSC genome
website.
To exclude the possibility of a de novo mutation
in the RUNX2 gene, we sequenced DNA fragments
ampliﬁed by PCR. The RUNX2 exons and pro-
moter regions were ampliﬁed using intron- and
exon-speciﬁc primers as described previously [Lee
FIG.2 .A: Wormian bones. B: Short clavicles. C: Dislocated radial head. D: Supernumerary-pseudoepiphyseal centers at the bases of the metacarpals 1, 2, and 5.
E: Hypoplastic pubic bones and mild hypoplasia of the ischia.
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normal.
To determine if small deletions or duplication
around translocation breakpoints may have contrib-
uted to the atypical ﬁndings seen in this patient, we
screened for cryptic copy number variants by
oligonucleotide-based array comparative genome
hybridization (aCGH). aCGH was performed using a
Human Genome CGH 244A Oligo Microarray Kit
(Agilent Technologies, Inc., Santa Clara, CA) accord-
ingtothemanufacturer’sprotocolversion4.0.Arrays
were scanned using an Agilent DNA Microarray
Scanner and data were extracted using Feature
Extraction Software 9.1 and analyzed using CGHA-
nalytics 3.4.27 Software (Agilent Technologies, Inc.,
Santa Clara, CA). DNA from a healthy male with no
personalorfamilyhistoryofCCDservedasacontrol.
A duplication of <77 kb was detected distal to the
BAK1 gene on chromosome 6p21.3. This region is
devoid of any known genes. All other copy number
changesidentiﬁedin the regions around 4p16,6p21,
and 21q21 were within copy number variant regions
previously described in the Database of Variants
hosted by the Centre for Applied Genomics (http://
projects.tcag.ca/variation/) or represented changes
in the HLA gene clusters on chromosome 6. No
obvious pathologic duplications or deletions were
found within the remainder of the genome.
DISCUSSION
CCD is a well-deﬁned clinical phenotype arising
from deregulation of intramembranous and endo-
chondral ossiﬁcation. The majority of cases are
due to loss of function mutations in the RUNX2 gene
that encodes for a transcription factor essential for
osteoblast differentiation and chondrocyte matura-
tion. Microdeletions and translocations involving
RUNX2explain an additional fractionofthe patients.
For proper skeletal development and homeostasis,
the expression of RUNX2 is tightly regulated during
development in a strict temporal and spatial fashion.
This regulation is achieved through regulatory
regions including two promoters [Napierala et al.,
2005]. The mouse RUNX2 gene also contains two
separate promoters [Xiao et al., 1998] and, in osteo-
blasts, RUNX2 expression is driven by the distal
bone-relatedpromoter.Napieralaetal.[2005]report-
edtwopatientswithpromotersequencevariantsand
hypothesized that promoter mutations affecting
FIG.3 .A: GTG-banding karyotype of lymphocytes of the patient. B: Idiogram of derivative chromosomes 4, 6, and 21, with their corresponding translocated
segments. C: DNA probes corresponding to chromosome 4p (red) and whole chromosome painting probe for chromosome 21 (green) and hybridized to metaphase
chromosomesandrevealedthatpartofchromosome21q(green)movedontochromosome4p:der(4)t(4p;21q).D:ThehybridizationofacombinationofDNAprobes
corresponding to WHS (red) on chromosome 4p and whole chromosome painting probe on chromosome 6p (green) revealed that WHS on chromosome 4p moved
ontochromosome6p:der(6)t(4p;6p).E:Thehybridizationofwholechromosomepaintingprobeofchromosome6(red)andchromosome21(green)revealedthatpart
ofchromosome6pmovedontochromosome21q:der(21)t(6p;21q).[Colorﬁgurecanbeviewedintheonlineissue,whichisavailableatwww.interscience.wiley.com.]
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expression might change the transcriptional activity
of the gene.
Although the main regulation of RUNX2 expression
is driven by two promoters, the promoter sequence
alone does not seem to be sufﬁcient for adequate
control of the expression. Additional cis-acting reg-
ulatorysequenceslocated200and400kbupstreamof
e x o n1h a v eb e e ni d e n t i ﬁed that act as enhancers of
theRUNX2gene[StockandOtto,2005].Thetransloca-
tion of the RUNX2 gene on 6p to chromosome 21 in
our patient may have disrupted a 50-control element,
such as an enhancer, resulting in haploinsufﬁciency
for RUNX2 and CCD phenotype. Given that in our
patientthebreakpointwas50kbupstreamofexon1of
the RUNX2 gene, this case suggests the location of a
novel RUNX2 regulatory element in this region.
A patient with a de novo reciprocal translocation
t(6;7)(p21.1;q36) with CCD and holoprosencephaly
has been reported [Fernandez et al., 2005]. The
authorsproposedthatthephenotypewasduetotwo
position effect mutations, one at each breakpoint,
altering the expression of the SHH (holoprosence-
phaly) and RUNX2 (CCD) genes. CCD-like pheno-
types have also been associated with de novo
cytogenetically balanced translocations: t(2;6)(q36;
q16) [Winer et al., 2003], and t(6;18)(p12;q24)
[Narahara et al., 1995]. A male patient with a
pericentric inversion of chromosome 6 and classic
CCD with mild to moderate mental retardation,
hearing deﬁcits, and unusual facial appearance has
also been reported [Nienhaus et al., 1993].
Atypical features seen in this patient cannot be
explained by dysregulation of RUNX2 expression.
The patient’s developmental delay, easy bruising,
and features of connective tissue disorder are not
characteristic of CCD. We hypothesize that disrup-
tion of additional genes on the other two chromo-
somes involved in the translocations (4 and 21)
contribute to this patient’s complex phenotype. The
possibility of microdeletions detectable by array
CGH has been excluded; however, the breakpoints
could have disrupted the coding sequence of
another gene, or resulted in positional effects
affecting other genes. Chromosome region 4p16
has the critical genes that, when deleted, result
in WHS (OMIM 194190), characterized by failure
to thrive, mental retardation, distinct facial features,
and seizures. Although our patient does not have
characteristicssuggestiveofWHS,itispossiblethata
gene involved in cognitive development could have
been affected. A gene involved in neural adhesion,
NCAM2 has been mapped to chromosome region
21q21.
Position effect mutations may result in disease
by repositioning genetic material and thereby lead-
ing to altered gene expression in the absence of
an intragenic change [Fernandez et al., 2005]. A
FIG.4 .A:SchematicrepresentationoftheRUNX2genomicregion,andrelativelocationoftheprobesusedforFISHmappingofthetranslocationbreakpointon6p21.
TheseincludeclonesRP1-244F24(AL096865),RP11-342L7(AL358135),andRP1-166H4(AL161907),andfosmidsG248P80212A10,G248P86676H4,G248P8418A1,and
G248P86565D3 located upstream of the RUNX2 gene. B: FISH with probe RP1-244F24 (red) showed signals on the normal and the derivative chromosome 6 and the
derivative chromosome 21.Atelomeric probefor6p(green) wasusedinB, C,and D.FISHwasperformedwithfosmids locatedupstreamofRUNX2:(C)Fosmid Probe
G248P86676H4 (red) was only seen on the normal and derivative chromosome 6 (not translocated); (D) Fosmid G248P80212A10 (red) showed a split signal, being
present on the normal chromosome 6 and both derivative chromosomes 6 and 21. [Color ﬁgure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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from distal regulatory elements or exert its effects on
chromatin structure. We propose that our patient’s
CCD phenotype is caused by disruption of a regu-
latory element for the RUNX2 gene at the 6p21
breakpoint causing altered expression of the gene
resultinginCCD.Furtherstudiesmightunravelanew
regulatory element for RUNX2.
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